Platelets, also known as thrombocytes, are small, disc-shaped cell fragments crucial for blood clotting and hemostasis. These tiny cells are derived from megakaryocytes in the bone marrow and play a vital role in preventing excessive bleeding by forming blood clots at sites of vascular injury. The primary function of platelets is to adhere to damaged blood vessel walls, become activated, and aggregate to form a plug that seals the breach. This process involves a sequence of events, including adhesion, release of granules containing clotting factors, and the activation of the coagulation cascade, ultimately leading to the formation of a stable blood clot. Platelets contain various granules, including alpha granules, dense granules, and lysosomes, which release factors essential for coagulation, vasoconstriction, and inflammation. Platelets also express surface receptors that enable them to interact with other blood components, promoting clot formation. Thrombopoietin, a hormone produced by the liver and kidneys, regulates platelet production. Platelets have a relatively short lifespan, typically surviving for about 7 to 10 days before being removed from circulation by the spleen and liver. Abnormalities in platelet function or quantity can lead to bleeding disorders or thrombotic conditions. Thrombocytopenia, characterized by a low platelet count, can result in excessive bleeding, while disorders like thrombocythemia can lead to an increased risk of abnormal blood clot formation. Platelet transfusions are a common medical intervention to address conditions associated with low platelet counts, such as in patients undergoing chemotherapy or with certain hematological disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States